摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tolylene-2,4-hydroxyethyl carbamide | 30042-54-7

中文名称
——
中文别名
——
英文名称
tolylene-2,4-hydroxyethyl carbamide
英文别名
1-(2-Hydroxyethyl)-3-[3-(2-hydroxyethylcarbamoylamino)-4-methylphenyl]urea
tolylene-2,4-hydroxyethyl carbamide化学式
CAS
30042-54-7
化学式
C13H20N4O4
mdl
——
分子量
296.326
InChiKey
CSZWNCZLDUWWNT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    21
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    123
  • 氢给体数:
    6
  • 氢受体数:
    4

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    KAZLAUSKAS D. A.; RAMOSHKENE EH. B., ZH. ORGAN. XIMII , 1976, 12, HO 7, 1527-1532
    摘要:
    DOI:
  • 作为产物:
    描述:
    参考文献:
    名称:
    Selective derivatization of oxime-blocked tolylene-2,4-diisocyanate
    摘要:
    A selective reaction of cyclohexanone oxime-blocked tolylene-2,4-diisocyanate (2,4-TDI) with amino siloxane was observed, in which amines were capable of discriminating two reactive groups in the 2,4-TDI molecule. Thus, tolylene-2-tert-butyldimethylsilyloxyethyl carbamide-4-cyclohexanone oxime carbamate was synthesized and its precise structure was determined by single-crystal X-ray diffraction. Moreover, it was found that oxime-blocked isocyanate could react selectively with the -NH2 group with the -OH group unprotected in ethanolamine. (C) 2013 Tian-Duo Li. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
    DOI:
    10.1016/j.cclet.2013.06.013
点击查看最新优质反应信息

文献信息

  • Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials
    申请人:Frechet Jean M.J.
    公开号:US20090220615A1
    公开(公告)日:2009-09-03
    Novel main chain acid degradable polymer backbones and drug delivery systems comprised of materials capable of delivering bioactive materials to cells for use as vaccines or other therapeutic agents are described. The polymers are synthesized using monomers that contain acid-degradable linkages cleavable under mild acidic conditions. The main chain of the resulting polymers readily degrade into many small molecules at low pH, but remain relatively stable and intact at physiological pH. The new materials have the common characteristic of being able to degrade by acid hydrolysis under conditions commonly found within the endosomal or lysosomal compartments of cells thereby releasing their payload within the cell. The materials can also be used for the delivery of therapeutics to the acidic regions of tumors and other sites of inflammation.
    本文介绍了一种新型主链酸可降解聚合物骨架和药物传递系统,由能够向细胞输送生物活性物质以用作疫苗或其他治疗剂的材料组成。这些聚合物是使用含有酸可降解键的单体合成的,这些键在温和酸性条件下可被裂解。由此产生的聚合物主链能够在低pH值下迅速降解为许多小分子,但在生理pH下仍相对稳定完整。这些新材料具有共同的特点,即能够在细胞内部体液或溶酶体等常见酸性条件下通过酸水解逐渐降解,从而释放其有效载荷。这些材料还可用于将治疗剂输送到肿瘤和其他炎症部位的酸性区域。
  • US8137700B2
    申请人:——
    公开号:US8137700B2
    公开(公告)日:2012-03-20
  • [EN] METHOD FOR REDUCING THE CONCENTRATION OF ISOCYANATES<br/>[FR] PROCEDE DESTINE A REDUIRE LA CONCENTRATION D'ISOCYANATES
    申请人:SUNFLOWER S R L
    公开号:WO2007015276A1
    公开(公告)日:2007-02-08
    [EN] Method for abating the concentration of isocyanate(s) in streams containing said isocyanate(s), said method comprising the step of putting said streams containing isocyanate(s) in contact with a solution of at least one compound selected from those having general formulae (Ia) and (Ib); wherein R, R',R'' are selected from hydrogen and hydrocarbyl groups having from 1 to 10 carbon atoms optionally containing heteroatoms; X is selected from the group consisting of nitrogen, phosphorus, as single atoms or as hydrocarbyl groups containing them; Y is selected from the group consisting of oxygen, sulphur, as single atoms or as hydrocarbyl groups containing them; Fg is selected from primary and secondary amines, -OH, -SH, preferably Fg is selected from -NH2 and -NHR1, wherein R1 is an alkyl group having from 1 to 6 carbon atoms; n is from 1 to 5, preferably from 1 to 2.
    [FR] L'invention concerne un procédé destiné à réduire la concentration d'isocyanate(s) dans des flux contenant ce/ces isocyanate(s), ce procédé comprenant les étapes consistant à placer ces flux contenant un/des isocyanate(s) en contact avec une solution d'au moins un composé sélectionné parmi ceux possédant la formule générale (Ia) et (Ib); R, R', R'' étant sélectionnés parmi des groupes d'hydrogène et d'hydrocarbyle possédant entre 1 et 10 atomes de carbone et contenant éventuellement des hétéroatomes; X étant sélectionné parmi le groupe constitué d'azote, de phosphore, en tant qu'atomes uniques ou en tant que groupes d'hydrocarbyle les contenant; Y étant sélectionné dans le groupe constitué d'oxygène, de soufre, en tant qu'atomes uniques ou en tant que groupes d'hydrocarbyle les contenant; Fg étant sélectionné parmi des amines primaires et secondaires, -OH, -SH, de préférence Fg étant sélectionnés parmi -NH2 et -NHR1, R1 représentant un groupe alkyle possédant entre 1 et 6 atomes de carbone; N valant entre 1 et 5 de préférence entre 1 et 2.
  • Selective derivatization of oxime-blocked tolylene-2,4-diisocyanate
    作者:Yang Sang、Peng-Fei Yang、Tian-Duo Li
    DOI:10.1016/j.cclet.2013.06.013
    日期:2013.11
    A selective reaction of cyclohexanone oxime-blocked tolylene-2,4-diisocyanate (2,4-TDI) with amino siloxane was observed, in which amines were capable of discriminating two reactive groups in the 2,4-TDI molecule. Thus, tolylene-2-tert-butyldimethylsilyloxyethyl carbamide-4-cyclohexanone oxime carbamate was synthesized and its precise structure was determined by single-crystal X-ray diffraction. Moreover, it was found that oxime-blocked isocyanate could react selectively with the -NH2 group with the -OH group unprotected in ethanolamine. (C) 2013 Tian-Duo Li. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
  • KAZLAUSKAS D. A.; RAMOSHKENE EH. B., ZH. ORGAN. XIMII <ZORK-AE>, 1976, 12, HO 7, 1527-1532
    作者:KAZLAUSKAS D. A.、 RAMOSHKENE EH. B.
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐